Induction of sustained remission in early inflammatory arthritis with the combination of infliximab plus methotrexate: the DINORA trial.

Document types check

Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/35909

Title:	Induction of sustained remission in early inflammatory arthritis with the combination of infliximab plus methotrexate: the DINORA trial.
Authors:	Stamm, Tanja Alexandra Machold, Klaus Peter Aletaha, Daniel Alasti, Farideh Lipsky, Peter Pisetsky, David Landewe, Robert van der Heijde, Desiree Sepriano, Alexandre Aringer, Martin Boumpas, Dimitri Burmester, Gerd Cutolo, Maurizio Ebner, Wolfgang Graninger, Winfried Huizinga, Tom Schett, Georg Schulze-Koops, Hendrik Tak, Paul-Peter Martin-Mola, Emilio Breedveld, Ferdinand Smolen, Josef View more
Keywords:	Clinical remission Early arthritis Rheumatoid arthritis View more
Mesh:	Adult Aged Antirheumatic Agents Arthritis, Rheumatoid Double-Blind Method Drug Therapy, Combination Female Humans Infliximab Male Methotrexate Middle Aged Remission Induction Treatment Outcome View more
Issue Date:	2018
Citation:	Arthritis Res. Ther..2018 08;(20)1:174
Abstract:	In the present study, we explored the effects of immediate induction therapy with the anti-tumour necrosis factor (TNF)α antibody infliximab (IFX) plus methotrexate (MTX) compared with MTX alone and with placebo (PL) in patients with very early inflammatory arthritis.
PMID:	30092827
URI:	https://hdl.handle.net/20.500.12530/35909
Rights:	openAccess
Appears in Collections:	Fundaciones e Institutos de Investigación > IIS H. U. La Paz > Artículos Hospitales > H. U. La Paz > Artículos

Files in This Item:

File	Description	Size	Format
PMC6085639.pdf		1.2 MB	Adobe PDF	View/Open